Literature DB >> 23960824

A validated stability-indicating LC method for estimation of etoposide in bulk and optimized self-nano emulsifying formulation: Kinetics and stability effects.

Naseem Akhtar1, Sushama Talegaonkar, Roop Kishan Khar, Manu Jaggi.   

Abstract

The present investigation was aimed to establish a validated stability-indicating liquid chromatographic method for the estimation of etoposide (ETP) in bulk drug and self-nano emulsifying formulation. ETP was successfully separated from the degradation products formed under stress conditions on LiChrospher 100 C18 reverse-phase column (a 250 mm × 4.6 mm i.d., 5-μm particle size) using 55:45 (v/v) acetonitrile-phosphate buffer saline (pH 4.5) as the mobile phase, at a flow rate of 1.0 mL min(-1) and detection at 283 nm. The response was a linear function of analyte concentration (R(2) > 0.9997) over the concentration range of 0.05-50 μg mL(-1). The method was validated for precision, accuracy, robustness, sensitivity and specificity. The % recovery of ETP at three different levels (50%, 100% and 150%) ranged between 93.84% and 100.06% in optimized self-nano emulsifying formulation, Etosid® soft-gelatin capsule and Fytosid® injection. First-order degradation kinetics of ETP were observed under acidic and alkaline conditions. The method was also applied for the stability assessment of self-nano emulsifying formulation under accelerated conditions, the formulation was found to be stable at all storage conditions with the shelf-life of 2.37 years at 25 °C. The method holds promise for routine quality control of ETP in bulk, pharmaceutical formulations as well as in stability-indicating studies.

Entities:  

Keywords:  Column liquid chromatography; Degradation kinetics; Etoposide; Forced degradation; Self-nano emulsifying formulation

Year:  2012        PMID: 23960824      PMCID: PMC3744973          DOI: 10.1016/j.jsps.2012.01.005

Source DB:  PubMed          Journal:  Saudi Pharm J        ISSN: 1319-0164            Impact factor:   4.330


  21 in total

1.  Simultaneous determination of etoposide and a piperine analogue (PA-1) by UPLC-qTOF-MS: evidence that PA-1 enhances the oral bioavailability of etoposide in mice.

Authors:  B S Sachin; I A Najar; S C Sharma; M K Verma; M V Reddy; R Anand; R K Khajuria; S Koul; R K Johri
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-02-06       Impact factor: 3.205

2.  Assay for etoposide in human serum using solid-phase extraction and high-performance liquid chromatography with fluorescence detection.

Authors:  K K Manouilov; T R McGuire; B G Gordon; P R Gwilt
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1998-04-10

3.  High-performance liquid chromatographic method for the determination of etoposide in plasma using electrochemical detection.

Authors:  G F Duncan; R H Farmen; H S Movahhed; K A Pittman
Journal:  J Chromatogr       Date:  1986-08-02

4.  A rapid reversed phase high performance liquid chromatographic method for determination of etoposide (VP-16) in human plasma.

Authors:  F H Shirazi; G Bahrami; D J Stewart; E Tomiak; F Delorme; D Noel; R Goel
Journal:  J Pharm Biomed Anal       Date:  2001-06       Impact factor: 3.935

Review 5.  The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review.

Authors:  Naseem Akhtar; Abdul Ahad; Roop Kishan Khar; Manu Jaggi; Mohammed Aqil; Zeenat Iqbal; Farhan Jalees Ahmad; Sushama Talegaonkar
Journal:  Expert Opin Ther Pat       Date:  2011-02-26       Impact factor: 6.674

6.  Simultaneous quantitation of etoposide and its catechol metabolite in human plasma using high-performance liquid chromatography with electrochemical detection.

Authors:  X Cai; M H Woo; M J Edick; M V Relling
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1999-05-28

7.  Development and bioavailability assessment of ramipril nanoemulsion formulation.

Authors:  Sheikh Shafiq; Faiyaz Shakeel; Sushma Talegaonkar; Farhan J Ahmad; Roop K Khar; Mushir Ali
Journal:  Eur J Pharm Biopharm       Date:  2006-10-24       Impact factor: 5.571

8.  Electrochemical study of the antineoplastic agent etoposide at carbon paste electrode and its determination in spiked human serum by differential pulse voltammetry.

Authors:  Abd-Elgawad Radi; Nadia Abd-Elghany; Tarek Wahdan
Journal:  Chem Pharm Bull (Tokyo)       Date:  2007-09       Impact factor: 1.645

9.  A validated HPTLC method for determination of terbutaline sulfate in biological samples: Application to pharmacokinetic study.

Authors:  Md Faiyazuddin; Abdul Rauf; Niyaz Ahmad; Sayeed Ahmad; Zeenat Iqbal; Sushma Talegaonkar; Aseem Bhatnagar; Roop K Khar; Farhan J Ahmad
Journal:  Saudi Pharm J       Date:  2011-04-01       Impact factor: 4.330

Review 10.  Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation.

Authors:  Tripta Bansal; Naseem Akhtar; Manu Jaggi; Roop K Khar; Sushama Talegaonkar
Journal:  Drug Discov Today       Date:  2009-08-06       Impact factor: 7.851

View more
  4 in total

1.  The Ameliorated Pharmacokinetics of VP-16 in Wistar Rats: A Possible Role of P-Glycoprotein Inhibition by Pharmaceutical Excipients.

Authors:  Naseem Akhtar; Abdul Ahad; Mohd Faiyaz Khan; Ayman Allaham; Sushama Talegaonkar
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-04       Impact factor: 2.441

2.  Biodegradability of the anticancer drug etoposide and identification of the transformation products.

Authors:  Tina Kosjek; Noelia Negreira; Ester Heath; Miren López de Alda; Damià Barceló
Journal:  Environ Sci Pollut Res Int       Date:  2016-05-24       Impact factor: 4.223

Review 3.  Common Chemical Inductors of Replication Stress:  Focus on Cell-Based Studies.

Authors:  Eva Vesela; Katarina Chroma; Zsofia Turi; Martin Mistrik
Journal:  Biomolecules       Date:  2017-02-21

4.  Stability of Paracetamol Instant Jelly for Reconstitution: Impact of Packaging, Temperature and Humidity.

Authors:  Samah Hamed Almurisi; Khater Al-Japairai; Farhan Alshammari; Fawaz Alheibshy; Rana M F Sammour; Abd Almonem Doolaanea
Journal:  Gels       Date:  2022-02-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.